Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
New Microbes New Infect ; 8: 28-30, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26594376

ABSTRACT

Spread of carbapenemase-producing bacteria has been described all over the world. This phenomenon may be accelerated by many factors, including wars and natural disasters. In this report, we described an NDM-1-producing Klebsiella pneumonia ST11 recovered from a patient injured during the Maidan revolution in Ukraine. To our knowledge, this is the first report of a carbapenemase-producing Enterobacteriaceae in Ukraine and one of several reports describing wound colonization/infection of humans injured during war.

2.
Epidemiol Mikrobiol Imunol ; 64(2): 87-91, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26099612

ABSTRACT

OBJECTIVE: One of the most important threats of current medicine is the spread of multiresistant Gram-negative bacteria. We report here data from a six-month prevalence study on carbapenemase-producing K. pneumoniae and E. coli performed in Czech hospitals participating on European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE). METHODS: Ten hospitals covering all regions of the Czech Republic were selected. During the study period (1st November 2013 to 30th April 2014), first ten carbapenem non-susceptible isolates of K. pneumoniae or E. coli isolated from non-surveillance specimens (i.e., blood, lower respiratory tract secretions, urine, puncture fluids, and wound secretions) of single successive patients were collected. Successive carbapenem-susceptible isolates of the same species were also preserved as controls. Susceptibility to 15 antibiotics was determined using EUCAST recommendations. Carbapenemase activity was detected by MALDI-TOF MS meropenem hydrolysis assay. Positive isolates were subjected for molecular typing (multi-locus sequence typing, identification of carbapenemase gene). RESULTS: During the study period, thirty non-susceptible isolates (K. pneumoniae n=28, E. coli n=2) were identified in 5 hospitals. Only two of them were confirmed to be carbapenemase producers. A NDM-1-producing K. pneumoniae ST11 was recovered from a patient, transferred from Ukraine, being injured during a Maidan revolution. The second isolate, an OXA-48-producing K. pneumoniae, belonging to ST101, was recovered from a patient admitted to a hospital for an ischemic stroke. CONCLUSIONS: This study again confirmed that the Czech Republic still belongs to the countries with low prevalence of carbapenemase-producing Enterobacteriaceae (CPE). Cases of CPE are usually restricted to an import from high-prevalence countries or countries with unknown epidemiological situation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Escherichia coli Infections/epidemiology , Escherichia coli/isolation & purification , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/isolation & purification , beta-Lactamases/metabolism , Bacterial Proteins/genetics , Bacterial Typing Techniques , Carbapenems/pharmacology , Cross-Sectional Studies , Czech Republic/epidemiology , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli Infections/microbiology , Geography , Hospitals , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Multilocus Sequence Typing , Prevalence , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Ukraine , beta-Lactamases/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...